Sort
25,944 grants matching “neurodegeneration”
Peroxidation / aggregation of cyt c-lipid - synuclein complexes
$254,606Valerian E Kagan · University Of Pittsburgh At Pittsburgh · P01 · FY2011 · NS
Peptide therapy for alcohol-induced CNS injury
$254,581Mohammed Abdul Muneer · Hackensack University Medical Center · R21 · FY2023 · AA
GENETICS CORE
$254,579Vivianna M Van Deerlin · University Of Pennsylvania · P01 · FY2008 · AG
A DNA origami platform for measuring membrane protein interactions
$254,531Paul W.k. Rothemund · California Institute Of Technology · R21 · FY2021 · MH
Detection of early cognitive change: Linking to clinically meaningful outcomes (Project 4)
$254,520Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2020 · AG
CORE--NEUROPATHOLOGY
$254,509University Of California San Diego · P50 · FY2004 · AG
Transcriptional Responses in Neurodegenerative Diseases
$254,486Robert P Bowser · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · NS
Design, synthesis and evaluation of selective Grp94 inhibitors
$254,420Gabriela Chiosis · Sloan-Kettering Inst Can Research · R21 · FY2010 · AI
An in situ Neuronal Model of PHF-TAU Accumulation in AD
$254,363University Of Massachusetts Lowell · R01 · FY2002 · AG
An in situ Neuronal Model of PHF-TAU Accumulation in AD
$254,363University Of Massachusetts Lowell · R01 · FY2003 · AG
An in situ Neuronal Model of PHF-TAU Accumulation in AD
$254,363University Of Massachusetts Lowell · R01 · FY2001 · AG
An in situ Neuronal Model of PHF-TAU Accumulation in AD
$254,363University Of Massachusetts Lowell · R01 · FY2004 · AG
Chemical Approaches for Studying the Biology of NAD-consuming Enzymes
$254,340Hening Lin · Cornell University · R01 · FY2016 · GM
Chemical Approaches for Studying the Biology of NAD-consuming Enzymes
$254,340Hening Lin · Cornell University · R01 · FY2017 · GM
Modulators of Rab9 Expression for the Treatment of Niemann-Pick C Disease
$254,250Yiannis A Ioannou · Icahn School Of Medicine At Mount Sinai · R21 · FY2009 · NS
Multiscale Modeling of Brain Aging and Alzheimerâs Disease with MRI, Pathology and Proteomics
$254,250Els Fieremans · New York University School Of Medicine · R21 · FY2024 · AG
Metabolomics of the Endosomal/Lysosomal System
$254,250Yiannis A Ioannou · Icahn School Of Medicine At Mount Sinai · R21 · FY2009 · NS
The genetic basis of singlet oxygen-mediated signaling in eukaryotic cells
$254,247Klaus Apel · Boyce Thompson Inst For Plant Research · R01 · FY2012 · GM
Age related determinants of HAND: A 12 year follow-up of CHARTER participants
$254,239Robert Kernachan Heaton · University Of California, San Diego · R01 · FY2021 · MH
Hydrolytic and Free Radical Mediated DNA Damage
$254,200Loma Linda University · R01 · FY2004 · GM
Hydrolytic and Free Radical Mediated DNA Damage
$254,200Loma Linda University · R01 · FY2003 · GM
Hydrolytic and Free Radical Mediated DNA Damage
$254,200Loma Linda University · R01 · FY2005 · GM
CSVD and AD: the drivers of late life dementia
$254,176Joanne McLaurin · Sunnybrook Research Institute · R01 · FY2022 · AG
Neuroinflammatory and cognitive consequences of losing cholinergic anti-inflammatory tone in the forebrain
$254,171Colm Cunningham · Trinity College Dublin · R01 · FY2018 · AG
Implantable MEMS Drug Delivery Device for Glaucoma Management
$254,158Ellis Meng · University Of Southern California · R21 · FY2007 · EY